Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/20427778
Conclusion of this study
Vitamin E was superior to placebo for the treatment of nonalcoholic steatohepatitis in adults without diabetes. There was no benefit of pioglitazone over placebo for the primary outcome; however, significant benefits of pioglitazone were observed for some of the secondary outcomes. (ClinicalTrials.gov number, NCT00063622.)
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study